Navigation Links
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
Date:9/5/2012

nts.  These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those projected in, or implied by, these forward-looking statements.  Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing governmental regulation, our ability to commercialize, manufacture and achieve market acceptance of any of our product candidates, for which we rely heavily on collaboration with third parties, and our ability to protect and enforce our intellectual property rights and to operate without infringing upon the proprietary rights of third parties. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements and no assurance can be given that the actual results will be consistent with these forward-looking statements.  For more information about the risks and uncertainties that may affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Commission, including our annual report on Form 10-K and quarterly reports on Form 10-Q. We do not intend to update any of the forward-looking statements after the date of this announcement to conform these statements to actual results, to changes in management's expectations or otherwise, except as may be required by law. Pharmacyclics, Inc.
Condensed Consolidated Balance Sheets
(unaudited; in thousands)June 30,2012June 30, 2011ASSETSCash, cash equivalents and marketable securities*

$

203,607

$

1
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- Endo International plc (NASDAQ: ENDP ) (TSX: ... acquire all of the outstanding shares of Auxilium Pharmaceuticals, Inc. ... of $28.10 in a cash and stock transaction valued at ... 31% to Auxilium,s closing price on September 16, 2014 and ... shares for the previous 30 days.  Under the terms of ...
(Date:9/16/2014)... YORK , Sept. 16, 2014  This report analyzes ... Units, The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... , and Rest of World. Annual estimates and forecasts ... seven-year historic analysis is provided for these markets. Market data ...
(Date:9/16/2014)... , Sept. 16, 2014 Adaptive Biotechnologies, a ... (NGS) to profile the adaptive immune system, is pleased ... as Chief Commercial Officer (CCO). The addition of Brain ... key hires from leading global healthcare companies, including ... (General Counsel) from Genomic Health and Sean Nolan ...
Breaking Medicine Technology:Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 3Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 4Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 5Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 6Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 7Global Digital Radiography Industry 2Global Digital Radiography Industry 3Global Digital Radiography Industry 4Global Digital Radiography Industry 5Global Digital Radiography Industry 6Global Digital Radiography Industry 7Global Digital Radiography Industry 8Global Digital Radiography Industry 9Global Digital Radiography Industry 10Global Digital Radiography Industry 11Global Digital Radiography Industry 12Global Digital Radiography Industry 13Global Digital Radiography Industry 14Global Digital Radiography Industry 15Global Digital Radiography Industry 16Global Digital Radiography Industry 17Global Digital Radiography Industry 18Global Digital Radiography Industry 19Global Digital Radiography Industry 20Global Digital Radiography Industry 21Global Digital Radiography Industry 22Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 2Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 3
(Date:9/16/2014)... CA (PRWEB) September 16, 2014 ... launch of two new product extensions, an accompanying ... headquarters, several novel marketing tools for their sales ... Vitamin Angels at their 5th annual national convention, ... room only crowd at the Hyatt Regency Orange ...
(Date:9/16/2014)... Recently, iFitDress.com, one of the most famous dress suppliers ... evening gown collection. According to the company’s sales manager, ... (up to 69% off) at present. Additionally, all the company’s ... am a frequent caller of your site. I like your ... feel quite happy. All items are of good quality. I ...
(Date:9/16/2014)... 2014 Today, Top10BestSEOHosting.com compares ... the USA and announces that HostMonster, Arvixe ... best Windows web hosting companies in the ... clients high quality WordPress hosting (including VPS ... , HostMonster provides outstanding customer support and ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Paradigm Physical ... offering a new therapeutic treatment for their patients. Dry ... to treat a variety of musculoskeletal problems. , In ... is inserted into the skin and muscle to create ... the needle, the needle helps to deactivate and release ...
(Date:9/16/2014)... September 16, 2014 Cliff Lake Dental Care ... Kristaleen is the newest dental hygienist to join Dr. Rauchwarter's ... to working with her and knows she will bring many ... , Kristaleen grew up in River Falls, WI. She ... College in 2003 and practiced dental assisting in the Twin ...
Breaking Medicine News(10 mins):Health News:New Products Announced at Jusuru International’s R2E14 National Convention 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 3Health News:New Products Announced at Jusuru International’s R2E14 National Convention 4Health News:iFitDress.com: One Shoulder Evening Gown Collection Unveiled Online 2Health News:Best Windows Web Hosting Suppliers Recommended By SEO Hosting Review Site Top10BestSEOHosting.com 2Health News:Paradigm Physical Therapy Introduces Dry Needling 2Health News:Cliff Lake Dental Care Announces Newest Team Member 2
... Data Shows a Comprehensive Technology Infrastructure Improves Efficiency, ... March 10 Two Kaiser Permanente studies published ... a comprehensive electronic health record can increase consumer ... clinical quality and that connecting patients directly with ...
... More physician leaders are embracing technological advances, such as ... and unresponsive to their needs.Those are the results found ... Physician Executives (ACPE). The findings were published in the ... of medical management.ACPE conducted the same survey back in ...
... N.Y., March 10 NBTY, Inc. (NYSE: ... and marketer of nutritional supplements, today announced that it ... Chief Financial Officer of NBTY, at the B. Riley ... Wednesday, March 18, 2009.The presentation is scheduled to be ...
... Adjusted FIFO EBITDA Increases 4.3% to $26.1 Million, Excluding ... Full Year Adjusted FIFO EBITDA Increases 15% to $90.5 ... Net Cash Provided by Operating Activities Increases 130% to ... Million and Full Year Net Loss of $72.8 Million ...
... in corrective surgery operations from 2007 and 2008. ... is breast augmentations (breast enlargements), tummy tucks and ... largest cosmetic surgeons in the UK, can reveal ... cosmetic procedures, with the figure worryingly increasing to ...
... Holdings Ltd,("Obio"/ "the Company") announced the discovery of a ... influenza virus (including avian and human,influenza strains) such as ... TG21 has already commenced. , ... in USA and,China to conduct various researches, all of ...
Cached Medicine News:Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 2Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 3Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 4Health News:Survey Results: Health Care Technology Advances as Physician Frustration Grows 2Health News:NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009 2Health News:NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009 3Health News:NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009 4Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 2Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 3Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 4Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 5Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 6Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 7Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 8Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 9Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 10Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 11Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 12Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 13Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 14Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 15Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 16Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 17Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 18Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 19Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 20Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 21Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 22Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 23Health News:Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery 2Health News:Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery 3Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 2Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 3
... intended for the immunochromatographic, qualitative determination ... Strip Gonorrhea is based on the ... determination of gonorrhea antigen in the ... system as an aid in the ...
The IntraStent DoubleStrut Biliary Stent represents a completely new direction in stent design. The combination of parallel struts and unique cell geometry provide unparalleled performance....
The Smart Check Syphilis Device is a qualitative membrane device based immunoassay for the detection of TP (Treponema Pallidum) antibodies in whole blood/serum/plasma. For professional in vitro diagn...
Bio-Quant, Inc. OneStep hCG InstaTest is an immunochromatographic assay designed for qualitative determination of human chorionic gonadotropin (hCG) in urine for early detection of pregnancy....
Medicine Products: